Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
International Urology and Nephrology
Erschienen in: International Urology and Nephrology 4/2011

01.12.2011 | Urology – Original Paper

Effects of pulsed electromagnetic fields on benign prostate hyperplasia

verfasst von: Xenophon K. Giannakopoulos, Christos Giotis, Spyridon Ch. Karkabounas, Ioannis I. Verginadis, Yannis V. Simos, Dimitrios Peschos, Angelos M. Evangelou

Erschienen in: International Urology and Nephrology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Benign prostate hyperplasia (BPH) has been treated with various types of electromagnetic radiation methods such as transurethral needle ablation (TUNA), interstitial laser therapy (ILC), holmium laser resection (HoLRP). In the present study, the effects of a noninvasive method based on the exposure of patients with BPH to a pulsative EM Field at radiofrequencies have been investigated.

Materials and methods

Twenty patients with BPH, aging 68–78 years old (y.o), were enrolled in the study. Patients were randomly divided into two groups: the treatment group (10 patients, 74.0 ± 5.7 y.o) treated with the α-blocker Alfusosin, 10 mg/24 h for at least 4 weeks, and the electromagnetic group (10 patients, 73.7 ± 6.3 y.o) exposed for 2 weeks in a very short wave duration, pulsed electromagnetic field at radiofrequencies generated by an ion magnetic inductor, for 30 min daily, 5 consecutive days per week. Patients of both groups were evaluated before and after drug and EMF treatment by values of total PSA and prostatic PSA fraction, acid phosphate, U/S estimation of prostate volume and urine residue, urodynamic estimation of urine flow rate, and International Prostate Symptom Score (IPSS).

Results

There was a statistically significant decrease before and after treatment of IPSS (P < 0.02), U/S prostate volume (P < 0.05), and urine residue (P < 0.05), as well as of mean urine flow rate (P < 0.05) in patients of the electromagnetic group, in contrast to the treatment group who had only improved IPSS (P < 0.05). There was also a significant improvement in clinical symptoms in patients of the electromagnetic group. Follow-up of the patients of this group for one year revealed that results obtained by EMFs treatment are still remaining.

Conclusion

Pulsed electromagnetic field at radiofrequencies may benefit patients with benign prostate hyperplasia treated by a non-invasive method.
Literatur
1.
Foster KR, Repacholi MH (2004) Biological effects of radiofrequency fields; does modulation matter? Rad Res 162:219–225CrossRef
2.
Tofani S, Cintorino M, Barone D et al (2002) Increased mouse survival, tumor growth inhibition and decreased immunoreactive P53, after exposure to magnetic fields. Bioelectromagnetics 23:230–238PubMedCrossRef
3.
Stronati L, Testa A, Villani P et al (2004) Absence of genotoxicity in human blood cells exposed to 50 Hz magnetic fields as assessed by comet assay, chromosome aberration, micronucleus, and sister chromatid exchange analyses. Bioelectromagnetics 25:41–48PubMedCrossRef
4.
Karkabounas S, Havelas K, Kostoula OK et al (2006) Effects of low intensity static electromagnetic fields on leiomyosarcoma and smooth muscle cell lines. Hell J Nucl Med 9:167–172PubMed
5.
Charles L, Loomis D, Shy C et al (2003) Electromagnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers. Am J Epidemiol 157:683–691PubMedCrossRef
6.
Sauer H, Hescheler J, Reis D et al (1977) DC electrical field-induced c-fos expression and growth stimulation in multicecellular prostate cancer spheroids. Br J Cancer 75:1481–1487CrossRef
7.
Islamov BI, Balabonova RN, Futnikov VA et al (2002) Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med 134:248–250PubMedCrossRef
8.
Athanasiou A, Karkabounas S, Batistatou A et al (2007) The effect of pulsed electromagnetic fields on secondary skin wound healing. An experimental study. Bioelectromagnetics 28:362–368PubMedCrossRef
9.
Weintraub MI, Wolfe GI, Barohn RA et al (2003) Static magnetic field therapy for symptomatic diabetic neuropathy: A randomized double-blind, placebo-controlled trial. Arch Phys Med Rehabil 84:736–746PubMedCrossRef
10.
Ahmed M, Bell T, Lawrenxe WT et al (1997) Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral of the prostate for the treatment of benign prostatic hyperplasia a randomized, controlled, parallel study. Br J Urol 79:181–185PubMedCrossRef
11.
Anson KM, Seenivasagam K, Watson GM (1994) Visual laser ablation of the prostate. Urology 43:276PubMedCrossRef
12.
Bagley D, Erhard M (1995) Use of the holmium laser in the upper urinary tract. Tech Urol 1:25–30PubMed
13.
Giannakopoulos X et al. (1996) Transurethral needle ablation (TUNA) of the prostate: preliminary results using the new generation TUNA III catheter on patients with symptomatic BPH controlled by a series of 50 patients using the TUNA II device. In: Abstracts of the XIIth Congress European Association of Urology, Paris, France, 1–4 September 1996
14.
Gilling PJ, Cass CB, Cresswell MD et al (1996) Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology 47:48–51PubMedCrossRef
15.
Madersbacher S, Pycha A, Klingler CH et al (1999) The International Prostate Symptom score in both sexes: a urodynamics-based comparison. Neurourol Urodyn 18:173–182PubMedCrossRef
16.
Anninos P, Papadopoulos I, Kotini A et al (2003) Differential diagnosis of prostate lesions with the use of biomagnetic measurements and non-linear analysis. Urol Res 31:32–36PubMed
17.
Bellofonte C, Vedruccio C, Tubolini P et al (2005) Non-invasive detection of prostate cancer by electromagnetic interaction. Eur Urol 47:29–37CrossRef
18.
Suss S (1997) Bioresonance therapy in the treatment of allergies. Every person has its own vibration pattern. Fortschr Med 115:16–18PubMed
19.
Panagopoulos JD, Messini N, Karabarbounis A et al (2000) A mechanism for action of oscillating electric fields on cells. Biochem Biophys Res 272:634–640CrossRef
20.
Chiabrera B, Bianco B, Moggia E et al (1994) Interaction mechanism between electromagnetic fields and ion absorption: endogenous forces and collision frequency. Bioelectrochem Bioenergetics 35:33–37CrossRef
21.
Carafoli E (2004) The ambivalent nature of calcium signal. J Endocrinol Invest 27:134–136PubMed
22.
Pessina GP, Aldimucci C, Palmi M et al (2001) Pulsed electromagnetic fields affect the intracellular calcium concentrations in human astrocytoma cells. Bioelectromagnetics 22:503–510PubMedCrossRef
23.
Ikehara T, Park KH, Yamagushi H et al (2002) Effects of time varying strong magnetic field on release of cytosolic free Ca2+ from intracellular stores in cultural bovine adrenal chromaffin cells. Bioelectromagnetics 23:505–515PubMedCrossRef
24.
Abeele FV, Skryma R, Shuba Y et al (2002) Bcl-2-dependent modulation of Ca2+ homeostasis and store operated channels in prostate cancer cells. Cancer Cell 1:169–179CrossRef
25.
Kramer G, Mittereyer D, Marbeger M (2007) Is benign prostate hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51:1202–1216PubMedCrossRef
26.
Johnson MT, Waite LR, Nindl G (2004) Non-invasive treatment of inflammation using electromagnetic fields: current and emerging therapeutic potential. Biomed Sci Instr 40:469–474
27.
Jorgensen WA, Frome BM, Wallach C (1994) Electrochemical therapy of pelvic pain: Effects of pulsed electromagnetic fields (PEMF) on tissue trauma. Eur J Surg Suppl 574:83–86PubMed
28.
Mihajlovic-Madzarevic V, Pappas P (2005) Treatment of refractory seizures due to a benign mass present in the corpus callosum with an ion magnetic inductor: case report. Brain Tumor Pathol 22:93–95PubMedCrossRef
Metadaten
Titel
Effects of pulsed electromagnetic fields on benign prostate hyperplasia
verfasst von
Xenophon K. Giannakopoulos
Christos Giotis
Spyridon Ch. Karkabounas
Ioannis I. Verginadis
Yannis V. Simos
Dimitrios Peschos
Angelos M. Evangelou
Publikationsdatum
01.12.2011
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 4/2011
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-011-9944-7

Weitere Artikel der Ausgabe 4/2011

International Urology and Nephrology 4/2011 Zur Ausgabe

Urology – Original Paper

The effect of testosterone treatment on urodynamic findings and histopathomorphology of pelvic floor muscles in female rats with experimentally induced stress urinary incontinence

Nephrology – Original Paper

Relationship between major adverse cardiac events and angiographic findings in dialysis patients

Urology – Original Paper

Management of blunt renal trauma: an experience in 84 children

Urology – Original Paper

Comparison of dartos flap and dartos flap plus spongioplasty to prevent the formation of fistulae in the snodgrass technique

Nephrology - Original Paper

Correlation between glycated hemoglobin and mean plasma glucose in hemodialysis patients

Urology – Original Paper

Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise